Brivissa 100 Tablet
Marketer
Arinna Lifescience Pvt Ltd
Salt Composition
Brivaracetam (100mg)
Overview Brivissa 100 Tablet
Epileptic seizures are managed with Brivissa 100mg tablets, an anticonvulsant medication. This medication, used either solely or in conjunction with other treatments, effectively prevents seizures while consistently administered. Brivissa 100mg functions by reducing abnormal brain electrical activity. Daily ingestion, with or without food, is recommended at the same time for optimal efficacy. Dosage frequency is determined individually by your physician to optimally control seizures and may be adjusted incrementally. Long-term use is typically advised; continued intake as prescribed is crucial, even during symptom-free periods. Discontinuing or missing doses risks seizure exacerbation; cessation should only occur under medical supervision due to the potential for increased seizure activity. Commonly reported side effects include nausea, vomiting, dizziness, and headaches. Behavioral changes such as irritability, aggression, and agitation may also occur, generally diminishing after the initial weeks of treatment. While most side effects are mild, some require medical attention. Suicidal ideation has been reported in a small percentage of patients; consult your doctor immediately if mood deterioration occurs. Prior to commencing treatment, inform your physician of any pre-existing liver or kidney disease, depression, suicidal thoughts, pregnancy, or pregnancy intentions. Breastfeeding mothers should also seek medical advice before using Brivissa 100mg tablets.
Primary Ingredients of Brivissa 100 Tablet
No information provided. Therefore, no text can be rewritten.
Uses of Brivissa 100 Tablet
Convulsive disorders
Major Benefits of Brivissa 100 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Brivissa 100 Tablet can be consumed with or without food; however, consistent timing is recommended.
Common Side effects of Brivissa 100 Tablet:
- Behavioral changes
- Agitation
- Aggressive behavior
- Dizziness
- Sedation
- Drowsiness
- Neuropsychiatric symptoms
How to use Brivissa 100 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; do not break, crush, or chew it. Brivissa 100 Tablets can be ingested with or without food, though consistent timing is recommended.
How Brivissa 100 Tablet works:
Brivissa 100 mg tablets are used to treat epilepsy. Their mechanism involves binding to SV2A receptors located on neuronal membranes. This action inhibits excessive neuronal firing within the brain, thereby preventing the propagation of seizure-inducing electrical impulses.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Brivissa 100 Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Brivissa 100 Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is recommended.
Breast feedingCONSULT YOUR DOCTOR
Data on Brivissa 100 Tablet use while breastfeeding is lacking. Seek your physician's advice.
DrivingUNSAFE
Taking Brivissa 100 Tablet may cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Brivissa 100 Tablet can be used safely by individuals with kidney impairment; dose modification is unnecessary. However, its use is not advised for those with end-stage renal disease, given the absence of supporting clinical trial evidence.
LiverCAUTION
Patients with hepatic impairment should use Brivissa 100mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Brivissa 100 Tablet :
NA
Facts to Know About Brivissa 100 Tablet
| Label | Value |
|---|---|
| Chemical Type | Levetiracetam Analog |
| Developing Habits | No. |
| Treatment Category | Central Nervous System (CNS) |
| Actions | AED: A protein ligand within synaptic vesicle 2 |




